ICD-10-CM Billable Code

M08.861

Other juvenile arthritis, right knee

Clinical Classification Guidelines

Medical Intelligence & Overview

Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a term used for a group of autoimmune diseases that cause persistent joint inflammation in children. When it affects the right knee, it can lead to pain, swelling, and stiffness, impacting daily activities and growth. ICD-10 code M08.861 specifically refers to cases where the inflammation occurs in the right knee. Recognizing the symptoms early and understanding potential causes can assist in managing the condition effectively.

Causes & Symptoms

Clinical Causes: Autoimmune response: The immune system mistakenly attacks the body's own joint tissues. Genetic factors: A family history of autoimmune diseases can increase risk. Environmental triggers: Infections or certain environmental factors may initiate or worsen the condition. Age and gender: It is more common in young children and tends to affect girls more than boys. Other underlying health conditions that influence immune function.

Key Symptoms: Persistent swelling and tenderness in the right knee Stiffness, especially in the morning or after periods of inactivity Pain during movement or palpation Reduced range of motion in the affected knee Warmth and redness over the joint Possible fever or skin rashes in some cases Fatigue and general irritability in some children

Diagnostic & Treatment

Diagnosis Path: Diagnosing juvenile arthritis involves a combination of physical examinations, medical history, and diagnostic tests. The healthcare provider will assess joint swelling, range of motion, and pain levels. Blood tests may be ordered to check for markers of inflammation or autoimmune activity, such as elevated ESR or CRP levels. Imaging studies, including X-rays or MRI scans, can evaluate joint damage or swelling. There is no single test for juvenile arthritis; diagnosis is based on clinical findings and ruling out other causes of joint symptoms.

Treatment Protocols: Although juvenile arthritis cannot be cured, several treatment options aim to control symptoms, prevent joint damage, and improve quality of life. Approaches can include: - Nonsteroidal anti-inflammatory drugs (NSAIDs): To reduce pain and inflammation. - Disease-modifying antirheumatic drugs (DMARDs): Such as methotrexate, to slow disease progression. - Biologic agents: Target specific parts of the immune system involved in inflammation. - Physical therapy: To preserve joint function, improve mobility, and strengthen muscles. - Regular exercise and activity modifications: To maintain joint health. - Pain management strategies: Including the use of heat or cold packs. - Monitoring and follow-up with healthcare providers to adjust treatments as needed. Early intervention and consistent management are essential in minimizing joint damage and helping children lead active lives.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.861 a billable ICD-10 code?
Yes, M08.861 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.861?
Clinical documentation must specify the nature of Other juvenile arthritis, right knee and any associated comorbidities for accurate reporting.

Cite this Clinical Reference